Učitavanje...
Bispecific antibodies targeting mutant RAS neoantigens
Mutations in the RAS oncogenes occur in multiple cancers, and ways to target these mutations has been the subject of intense research for decades. Most of these efforts are focused on conventional small-molecule drugs rather than antibody-based therapies because the RAS proteins are intracellular. P...
Spremljeno u:
| Izdano u: | Sci Immunol |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8141259/ https://ncbi.nlm.nih.gov/pubmed/33649101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciimmunol.abd5515 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|